Characteristics of ambulatory anticoagulant adverse drug events: A descriptive study

Thrombosis Journal

Volumn 8, Issue , 2010, Pages

  Long, Andrea L ^a   Bendz, Lisa ^b   Horvath, Monica M ^a   Cozart, Heidi ^a   Eckstrand, Julie ^a   Whitehurst, Julie ^a   Ferranti, Jeffrey ^a  

^a DUKE UNIVERSITY HEALTH SYSTEM   (United States)

^b DUKE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; CLOPIDOGREL; COTRIMOXAZOLE; ENOXAPARIN; FRESH FROZEN PLASMA; HEPARIN; IBUPROFEN; MOXIFLOXACIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; VITAMIN K GROUP; WARFARIN;

ADULT; AGED; AMBULATORY CARE; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; DEEP VEIN THROMBOSIS; DESCRIPTIVE RESEARCH; DRUG OVERDOSE; ELECTRONIC PRESCRIBING; ERYTHROCYTE TRANSFUSION; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE UTILIZATION; HEART ATRIUM FIBRILLATION; HEMARTHROSIS; HEMATOMA; HEMATURIA; HEMOPTYSIS; HOSPITAL ADMISSION; HOSPITALIZATION COST; HUMAN; HYPERCOAGULABILITY; INFORMATION TECHNOLOGY; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; PATIENT CARE; PATIENT MONITORING; RETROPERITONEAL HEMORRHAGE; UNIVERSITY HOSPITAL;

EID: 77949430720     PISSN: None     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-8-5     Document Type: Article

References (38)

1. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997, 277:301-6. 10.1001/jama.277.4.301, 9002492.
2. Jha AK, Kuperman GJ, Teich JM, Leape L, Shea B, Rittenberg E, Burdick E, Seger DL, Vliet M, Bates DW. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc 1998, 5:305-14. 61304, 9609500.
3. Thomsen LA, Winterstein AG, Sondergaard B, Haugbolle LS, Melander A. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother 2007, 41:1411-26. 10.1345/aph.1H658, 17666582.
4. Gandhi TK, Burstin HR, Cook EF, Puopolo AL, Haas JS, Brennan TA, Bates DW. Drug complications in outpatients. J Gen Intern Med 2000, 15:149-54. 10.1046/j.1525-1497.2000.04199.x, 1495358, 10718894.
5. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, Seger DL, Shu K, Federico F, Leape LL, Bates DW. Adverse drug events in ambulatory care. N Engl J Med 2003, 348:1556-64. 10.1056/NEJMsa020703, 12700376.
6. Ferranti J, Horvath M, Cozart H, Whitehurst J, Eckstrand J, Pietrobon R, Rajgor D, Ahmad A. A multifaceted approach to safety: The synergistic detection of adverse drug events in adult inpatients. J Pat Safety 2008, 4:184-90.
7. Fang MC, Go AS, Chang Y, Hylek EM, Henault LE, Jensvold NG, Singer DE. Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med 2007, 120:700-5. 10.1016/j.amjmed.2006.07.034, 17679129.
8. Woods DM, Thomas EJ, Holl JL, Weiss KB, Brennan TA. Ambulatory care adverse events and preventable adverse events leading to a hospital admission. Qual Saf Health Care 2007, 16:127-31. 10.1136/qshc.2006.021147, 17403759.
9. Budnitz DS, Pollock DA, Mendelsohn AB, Weidenbach KN, McDonald AK, Annest JL. Emergency department visits for outpatient adverse drug events: demonstration for a national surveillance system. Ann Emerg Med 2005, 45:197-206. 10.1016/j.annemergmed.2004.09.020, 15671977.
10. Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cadoret C, Fish LS, Garber L, Kelleher M, Bates DW. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003, 289:1107-16. 10.1001/jama.289.9.1107, 12622580.
11. Jha AK, Kuperman GJ, Rittenberg E, Teich JM, Bates DW. Identifying hospital admissions due to adverse drug events using a computer-based monitor. Pharmacoepidemiol Drug Saf 2001, 10:113-9. 10.1002/pds.568, 11499849.
12. Hafner JW, Belknap SM, Squillante MD, Bucheit KA. Adverse drug events in emergency department patients. Ann Emerg Med 2002, 39:258-67. 10.1067/mem.2002.121401, 11867978.
13. Budnitz DS, Shehab N, Kegler SR, Richards CL. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 2007, 147:755-65.
14. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2008, 133:160S-98S. 8, 10.1378/chest.08-0670, 18574265.
15. Wysowski DK, Nourjah P, Swartz L. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med 2007, 167:1414-9. 10.1001/archinte.167.13.1414, 17620536.
16. Joint Commission: 2008 National Patient Safety Goals. , http://www.jointcommission.org/PatientSafety/NationalPatientSafetyGoals/ 08_npsgs.htm
17. Ferranti J, Horvath M, Cozart H, Whitehurst J, Eckstrand J. Re-evaluating the safety profile of pediatrics: A comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment. Pediatrics 2008, 121:e1201-e7. 10.1542/peds.2007-2609, 18450863.
18. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981, 30:239-45.
19. Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, Pengo V, Erba N, Moia M, Ciavarella N, Devoto G, Berrettini M, Musolesi S. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996, 348:423-8. 10.1016/S0140-6736(96)01109-9, 8709780.
20. Hammons T, Piland NF, Small SD, Hatlie MJ, Burstin HR. Ambulatory patient safety. What we know and need to know. J Ambul Care Manage 2003, 26:63-82.
21. Plews-Ogan ML, Nadkarni MM, Forren S, Leon D, White D, Marineau D, Schorling JB, Schectman JM. Patient safety in the ambulatory setting. A clinician-based approach. J Gen Intern Med 2004, 19:719-25. 10.1111/j.1525-1497.2004.30386.x, 1492477, 15209584.
22. Ammenwerth E, Schnell-Inderst P, Machan C, Siebert U. The effect of electronic prescribing on medication errors and adverse drug events: A systematic review. J Am Med Inform Assoc 2008, 15:585-600. 10.1197/jamia.M2667, 2528040, 18579832.
23. Gandhi TK, Weingart SN, Seger AC, Borus J, Burdick E, Poon EG, Leape LL, Bates DW. Outpatient prescribing errors and the impact of computerized prescribing. J Gen Intern Med 2005, 20:837-41. 10.1111/j.1525-1497.2005.0194.x, 1490201, 16117752.
24. Metlay JP, Hennessy S, Localio AR, Han X, Yang W, Cohen A, Leonard CE, Haynes K, Kimmel SE, Feldman HI, Strom BL. Patient reported receipt of medication instructions for warfarin is associated with reduced risk of serious bleeding events. J Gen Intern Med 2008, 23:1589-94. 10.1007/s11606-008-0708-8, 2533388, 18618191.
25. Tang PC, Ash JS, Bates DW, Overhage JM, Sands DZ. Personal health records: definitions, benefits, and strategies for overcoming barriers to adoption. J Am Med Inform Assoc 2006, 13:121-6. 10.1197/jamia.M2025, 1447551, 16357345.
26. Cimino JJ, Patel VL, Kushniruk AW. The patient clinical information system (PatCIS): technical solutions for and experience with giving patients access to their electronic medical records. Int J Med Inform 2002, 68:113-27. 10.1016/S1386-5056(02)00070-9, 12467796.
27. The Markle Foundation--Connecting For Health: The Personal Health Working Group Final Report. , http://www.connectingforhealth.org/workinggroups/personalhealthwg.html
28. Ralston JD, Carrell D, Reid R, Anderson M, Moran M, Hereford J. Patient web services integrated with a shared medical record: patient use and satisfaction. J Am Med Inform Assoc 2007, 14:798-806. 10.1197/jamia.M2302, 2213480, 17712090.
29. Gardiner C, Longair I, Pescott MA, Erwin H, Hills J, Machin SJ, Cohen H. Self-monitoring of oral anticoagulation: does it work outside trial conditions?. J Clin Pathol 2009, 62:168-71. 10.1136/jcp.2008.059634, 2629005, 19181634.
30. Havrda DE, Hawk TL, Marvin CM. Accuracy and precision of the CoaguChek S versus laboratory INRs in a clinic. Ann Pharmacother 2002, 36:769-75. 10.1345/aph.1A310, 11978150.
31. Ryan F, O'Shea S, Byrne S. he reliability of point-of-care prothrombin time testing. A comparison of CoaguChek S and XS INR measurements with hospital laboratory monitoring. Int J Lab Hematol 2010, 32:Te26-33.
32. Gardiner C, Williams K, Mackie IJ, Machin SJ, Cohen H. Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. Br J Haematol 2005, 128:242-7. 10.1111/j.1365-2141.2004.05300.x, 15638860.
33. Heneghan C, Alonso-Coello P, Garcia-Alamino JM, Perera R, Meats E, Glasziou P. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 2006, 367:404-411. 10.1016/S0140-6736(06)68139-7, 16458764.
34. Kamali F, Wynne H. Pharmacogenetics of warfarin. Annu Rev Med e-pub August 9 2009.
35. You JHS, Tsui KKN, Wong RSM, Cheng G. Potential clinical and economic outomes of CYP2C9 andVKORC1 genotype-guided dosing in patients starting warfarin therapy. Clin Pharmacol Ther 2009, 86:540-7. 10.1038/clpt.2009.104, 19571807.
36. Gage BF, Lesko LJ. Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues. J Thromb Thrombolysis 2008, 25:45-51. 10.1007/s11239-007-0104-y, 17906972.
37. van Schie RM, Wadelius MI, Kamali F, Daly AK, Manolopoulos VG, de Boer A, Barallon R, Verhoef TI, Kirchheiner J, Haschke-Becher E, Briz M, Rosendaal FR, Redekop WK, Pirmohamed M, Zee AH. Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design. Pharmacogenomics 2009, 10:1687-95. 10.2217/pgs.09.125, 19842940.
38. Oake N, Fergusson DA, Forster AJ, van Walraven C. Frequency of adverse events in patients with poor anticoagulation: a meta-analysis. CMAJ 2007, 176:1589-94. 1867836, 17515585.